US-based games maker SCVNGR has raised $9m in funding from T-Venture, the venture unit of Deutsche Telekom, for its mobile payment service LevelUp. It is the second tranche of a larger Series D round investment, and brings the total raised from the round to $21m. SCVNGR’s first close of the round in June raised $12m.… Continue reading SCVNGR Levels Up with Deutsche Telekom
Month: August 2012
Google hooks on to MediaSpike
MediaSpike, a California-based company looking to monetise gaming through in-game product placement, has attracted the attention of US-based search engine Google’s corporate venturing unit as a backer in a seed round of funding. Joining Google Ventures in the investment are Raptor Capital Management affiliated venture fund Raptor Ventures, venture fund Venture51, actor Robert Downey Junior’s… Continue reading Google hooks on to MediaSpike
The Big Deal: long-term investing
There was a nice line at the UK government’s venture investment conference last week from a venture capitalist saying that most of the returns from healthcare deals it had done came between 15 and 25 years after the portfolio company had been founded. The point by Tim Haines, partner at venture capital (VC) firm Abingworth,… Continue reading The Big Deal: long-term investing
Burrill bores into $505m fund
US-based merchant bank Burrill & Company has made a second closing of its latest healthcare fund at $505m after corporations joined. The fundraising followed the $2.6bn raised by venture capital firm New Enterprise Associates earlier this year, with more than $700m targeted for life sciences. Although corporations are known to have joined Burrill’s fund as… Continue reading Burrill bores into $505m fund
OvaScience hatches with $37m
OvaScience, a US-based fertility company, has raised $37m in its series B round.
Intrexon closes at $100m
Intrexon, a US-based synthetic biology company, has closed its series E round at $100m, bringing the company’s total capital raised to more than $259m. New investors took the majority of the round while existing investors, including billionaire Randal Kirk, Intrexon’s executive chairman, through his Third Security venture investment unit, and Sandbox Industries, a venture capital… Continue reading Intrexon closes at $100m
Fidelity preps biotech expansion
US-based mutual fund manager Fidelity Investments’s biosciences venture unit is to launch a UK operation next month. Fidelity Biosciences, which has Fidelity as its limited partner, is one of the largest venture units in life sciences with an 18-strong team and Simon Clark, managing partner of the separate Fidelity Growth Partners, said last week the… Continue reading Fidelity preps biotech expansion
Pierson joins Syngenta Ventures
David Pierson joins Syngenta Ventures after seven years as a partner at US-based Intersouth
BlueRun’s funding marathon
Should BlueRun have difficulties that could make it harder for other corporate venturing groups looking to spin out.
Plink raises $3m
Matomy previously invested in the $633,000 round for Plink alongside Ahlborg Acquisitions.
Xoom heads to its IPO
The company has confidentially filed with US regulator Securities and Exchange Commission, and has hired US-based bank Goldman Sachs as lead underwriter, according to news provider Reuters.
Roche helps CytomX raise $41m
CytomX, which develops antibodies, previously raised $5m in its series A from angels, according to news provider VentureWire.
Oversi sells to Allot
Allot is paying $16m in cash, and up to $5m based on this year’s performance. Oversi will add $2m in revenues to Allot.
Intel motions Movea to $8.1m
Intel led the round, which was joined by venture firms iSource and GIMV.